Netharland Journal of Critical Care
2009,
Volume 13,
Issue 6
: 297-302
Review
Treatment of ethylene glycol and methanol poisoning: Why ethanol?
Abstract
Ethanol and fomepizole are used as antidotes for poisoning with ethylene glycol or methanol. Both ethylene glycol and methanol are metabolized by the enzyme alcohol dehydrogenase. Ethanol is a substrate for alcohol dehydrogenase and fomepizole is an inhibitor of this enzyme. This review pays attention to the differences between ethanol and fomepizole. The advantages and disadvantages of both antidotes are reviewed. Some authors claim fomepizole may prove able to eliminate the need for haemodialysis in certain patient groups. This may only hold true if fomepizole treatment is started shortly after the intake of a relatively low quantity of a toxic alcohol. Contrary to many authors, it is our opinion that fomepizole will prove unable to obviate the need for haemodialysis. The use of haemodialysis in addition to treatment with the antidotes is described. Haemodialysis not only removes the toxic alcohol and its metabolites, but is also helpful in correcting the metabolic imbalance. Taking account of the low availability, the side effects, high costs, and limited registration of fomepizole, we believe that ethanol still is the antidote of choice for poisoning with ethylene glycol and methanol. Copyright © 2009, Nederlandse Vereniging voor Intensive Care. All Rights Reserved.
Keywords
Antidotes
Ethanol
Ethyllene glycol
Fomepizolel
Methanol
Poisoning
License
Copyright (c) Netharland Journal of Critical Care
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Neth. J. Crit. Care open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Right ventricular failure: Is it relevant for the intensivist?
Neuropsychological Predictors of Violent Criminal Behavior
Raymond H. Ellis,
Shruti Banerjee,
Kazuo Takayama
1-6
Postoperative renal replacement therapy after hydroxyethyl starch infusion: A meta-analysis of randomised trials
Wilkes M.M.,
Navickis R.J.
4-9
Pocus series: Focused transoesophageal echocardiography, a view from the inside
Elzo Kraemer C.V.,
López Matta J.E.,
Friedericy H.J.,
Elzo Kraemer A.X.,
Tuinman P.R.,
van Westerloo D.J.,
Boogers J.M.J.
130-139